Aug 13, 2026 04:15PM
Aug 6, 2026 08:01AM
Aug 6, 2026 08:00AM
Jul 14, 2026 08:01AM
Jul 14, 2026 08:00AM
Jun 26, 2026 08:02AM
Jun 26, 2026 08:00AM Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
May 15, 2026 04:15PM
May 12, 2026 08:09AM
May 12, 2026 08:00AM
May 8, 2026 08:00AM
Apr 16, 2026 08:04AM
Apr 16, 2026 08:00AM
Apr 9, 2026 06:13AM Ensysce Biosciences (ENSC) files for 20.34M share offering by selling stockholders
Apr 7, 2026 08:17AM
Apr 7, 2026 08:00AM
Mar 31, 2026 06:51AM
Mar 30, 2026 04:50PM
Mar 4, 2026 08:45AM
Mar 3, 2026 08:02AM
Mar 3, 2026 08:00AM Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
Feb 25, 2026 08:00AM
Feb 23, 2026 08:00AM
Jan 28, 2026 08:02AM
Jan 28, 2026 08:00AM
Jan 21, 2026 08:03AM
Jan 21, 2026 08:00AM
Jan 8, 2026 08:00AM Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection
Jan 5, 2026 08:03AM
Jan 5, 2026 08:00AM
Dec 9, 2025 08:00AM
Dec 9, 2025 08:00AM
Dec 2, 2025 08:05AM
Dec 2, 2025 08:00AM
Nov 20, 2025 08:00AM Ensysce Biosciences receives FDA approval for PF614 manufacturing approach
Nov 20, 2025 08:00AM
Nov 17, 2025 08:06AM
Nov 17, 2025 08:05AM
Nov 16, 2025 11:46PM
Nov 14, 2025 04:15PM
Sep 4, 2025 08:00AM
Aug 19, 2025 08:00AM Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025
Aug 13, 2025 06:15PM
Aug 13, 2025 04:15PM
Jul 31, 2025 08:00AM
Jul 31, 2025 08:00AM
Jul 16, 2025 08:00AM
Jul 16, 2025 08:00AM
Jun 24, 2025 08:00AM Ensysce Biosciences Accelerates PF614-MPAR-102 Study with Full Enrollment of Part 2
Jun 11, 2025 08:00AM

435,845 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All